Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Laekna Limited
Merck Sharp & Dohme LLC
Ludwig Institute for Cancer Research
Jiangsu HengRui Medicine Co., Ltd.
University of Alabama at Birmingham
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Cancer Trials Ireland
Ono Pharmaceutical Co. Ltd
SCRI Development Innovations, LLC
M.D. Anderson Cancer Center
AIO-Studien-gGmbH
Novartis
Swiss Cancer Institute
Sun Yat-sen University
SWOG Cancer Research Network
Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
University of Southern California
Dana-Farber Cancer Institute
University of Miami
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University of Arizona
Johannes Gutenberg University Mainz
Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Medical University of Vienna
Swiss Cancer Institute
Swiss Cancer Institute
Swiss Cancer Institute
Case Comprehensive Cancer Center
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido Gastrointestinal Cancer Study Group
Dana-Farber Cancer Institute